Bogus Doctors in focus as HPCSA Warns on Rising Fraud
Bogus doctors remain a serious risk, says the HPCSA, as arrests rise and patients are urged to verify practitioners on the online register.
Barrs Pharmaceuticals Secures R92m Hetero Investment
Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
GLP-1 Weight Loss Drugs Reshape Obesity Care In South Africa
GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers.
HIV Prevention in SA Needs Local Lenacapavir Manufacturing
HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.
Lenacapavir Approved for HIV Prevention in South Africa
Lenacapavir has been registered by SAHPRA as an innovative HIV prevention injection. Find out more about its rollout in South Africa.
Aspen Targets Mounjaro Expansion in Africa Following Approval
Aspen's Mounjaro expansion plans promise to enhance diabetes and weight management treatment in Sub-Saharan Africa soon.
Aspen Boosted by Mounjaro: A New Era in Weight Loss
Aspen shares soar following the approval of Mounjaro for weight loss in South Africa. Discover the impact on obesity management.
Surge in Illicit Medicines Threatens Public Health
Understand the impact of the surge in illicit medicines on public health in South Africa and the measures being taken to protect patients.
Medical Device Regulation and Its Importance Today
Understand the risks of inadequate medical device regulation and why oversight is crucial for patient safety in South Africa.
Regulatory Delays Threaten Africa’s Pharmaceutical Ambition
Regulatory delays are hindering Africa's R1.25-trillion pharmaceutical manufacturing goals and access to markets.